That broader availability though still limited may be what's driving GLP-1 usage higher overall
The GH response to secretagogues is saturable: beyond a certain point, additional GHRP-2 does not produce proportionally more GH because the pituitarys releasable pool and the receptor system are finite, and somatostatin feedback increasingly opposes release
Starosta A, Gordon CE, Hornstein MD
Ohta K, Miki T, Warita K, Suzuki S, Kusaka T, Yakura T, et al
In a major step forward, the FDA approved the first generic liraglutide for weight loss in August 2025, making these treatments more affordable
Thats where semaglutide drugs come in